What's behind the U.S. mail service pharmacy's fast paced growth? This updated Kalorama Information report details why mail service pharmacy sales grew faster than those of any other segment of the U.S. retail pharmacy market in 1997. It examines the latest developments in the market, including the impact of managed care and pharmacy benefit management on the pharmaceutical industry. It provides U.S. market estimates for 1993-2003, and covers ten product segments, including: antiarthritics, antihistamines, anti-infectives, cardiovascular drugs, diabetes drugs, diuretics, hormones, psychotropics, respiratory drugs, and ulcer drugs. Leading competitors in the mail service industry are profiled.

Related Reports:

Anesthesia Drugs: Worldwide Markets
Jul 1, 2007 - KLI1399472 - $2,995.00

Critical Care Pharmaceutical Markets: A Strategic Analysis
Jun 1, 2006 - KLI1189532 - $2,995.00

Direct-to-Consumer Pharmaceutical Marketing 2005: Controversies Continue
Apr 1, 2005 - KLI1030057 - $1,995.00

Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003
Mar 1, 2004 - KLI959630 - $795.00

Successful Commercialization Strategies for New Healthcare Products and Technologies
Jun 1, 2003 - KLI875436 - $1,496.00

MarketLooks: The Market for Other Adjunctive Therapies in Cancer
Apr 1, 2002 - MLK762110 - $399.00

The Pharmaceutical Contract Manufacturing Marketplace
Jan 1, 2002 - KLI484002 - $2,625.00

The U.S. Market and Developments Associated with Psoriasis
Jul 1, 2001 - KLI433013 - $1,496.00

MarketLooks: Opportunities in Immunotherapy
Apr 1, 2001 - ML0966 - $399.00

Current Developments in Immunotherapy Markets and Technology
Apr 1, 2001 - KLI26 - $2,812.00